123 related articles for article (PubMed ID: 1728908)
1. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.
Wassertheil-Smoller S; Blaufox MD; Oberman AS; Langford HG; Davis BR; Wylie-Rosett J
Arch Intern Med; 1992 Jan; 152(1):131-6. PubMed ID: 1728908
[TBL] [Abstract][Full Text] [Related]
2. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
Wassertheil-Smoller S; Oberman A; Blaufox MD; Davis B; Langford H
Am J Hypertens; 1992 Jan; 5(1):37-44. PubMed ID: 1736933
[TBL] [Abstract][Full Text] [Related]
3. Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group.
Davis BR; Oberman A; Blaufox MD; Wassertheil-Smoller S; Hawkins CM; Cutler JA; Zimbaldi N; Langford HG
Hypertension; 1992 Apr; 19(4):393-9. PubMed ID: 1555871
[TBL] [Abstract][Full Text] [Related]
4. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy.
Blaufox MD; Lee HB; Davis B; Oberman A; Wassertheil-Smoller S; Langford H
JAMA; 1992 Mar; 267(9):1221-5. PubMed ID: 1538559
[TBL] [Abstract][Full Text] [Related]
5. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
Davis BR; Blaufox MD; Oberman A; Wassertheil-Smoller S; Zimbaldi N; Cutler JA; Kirchner K; Langford HG
Arch Intern Med; 1993 Aug; 153(15):1773-82. PubMed ID: 8333814
[TBL] [Abstract][Full Text] [Related]
6. Effect of antihypertensives on sexual function and quality of life: the TAIM Study.
Wassertheil-Smoller S; Blaufox MD; Oberman A; Davis BR; Swencionis C; Knerr MO; Hawkins CM; Langford HG
Ann Intern Med; 1991 Apr; 114(8):613-20. PubMed ID: 2003706
[TBL] [Abstract][Full Text] [Related]
7. Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management.
Davis BR; Oberman A; Blaufox MD; Wassertheil-Smoller S; Zimbaldi N; Kirchner K; Wylie-Rosett J; Langford HG
Am J Hypertens; 1994 Oct; 7(10 Pt 1):926-32. PubMed ID: 7826557
[TBL] [Abstract][Full Text] [Related]
8. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
Curry RC; Schwartz KM; Urban PL
South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group.
Langford HG; Davis BR; Blaufox D; Oberman A; Wassertheil-Smoller S; Hawkins M; Zimbaldi N
Hypertension; 1991 Feb; 17(2):210-7. PubMed ID: 1671380
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effectiveness of a beta blocker (atenolol) and a diuretic (chlorthalidone) in black hypertensive patients.
Grell GA; Forrester TE; Alleyne GA
South Med J; 1984 Dec; 77(12):1524-9. PubMed ID: 6390696
[TBL] [Abstract][Full Text] [Related]
11. Atenolol and chlorthalidone in combination for hypertension.
Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
[TBL] [Abstract][Full Text] [Related]
12. Trial of atenolol and chlorthalidone for hypertension in black South Africans.
Seedat YK
Br Med J; 1980 Nov; 281(6250):1241-3. PubMed ID: 7000296
[TBL] [Abstract][Full Text] [Related]
13. Commentary on the Trial of Antihypertensive Interventions and Management (TAIM) Study.
Kaplan NM
Am J Hypertens; 1992 Jan; 5(1):47-8. PubMed ID: 1736935
[No Abstract] [Full Text] [Related]
14. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status.
Oberman A; Wassertheil-Smoller S; Langford HG; Blaufox MD; Davis BR; Blaszkowski T; Zimbaldi N; Hawkins CM
Ann Intern Med; 1990 Jan; 112(2):89-95. PubMed ID: 1967210
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
16. Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise.
Costa FV; Borghi C; Mussi A; Ambrosioni E
Eur J Clin Pharmacol; 1986; 30(2):145-50. PubMed ID: 3709638
[TBL] [Abstract][Full Text] [Related]
17. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination.
Durel LA; Hayashi PJ; Weidler DJ; Schneiderman N
J Clin Pharmacol; 1992 Jun; 32(6):564-70. PubMed ID: 1634645
[TBL] [Abstract][Full Text] [Related]
19. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
Fogari R; Zoppi A
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
[TBL] [Abstract][Full Text] [Related]
20. Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
Webster J; Jeffers TA; Galloway DB; Petrie JC; Barker NP
Br Med J; 1977 Jan; 1(6053):76-8. PubMed ID: 12850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
